144 related articles for article (PubMed ID: 22513794)
1. Nephrotic syndrome leading to the diagnosis of classical Hodgkin's lymphoma in a 13-year-old girl.
Escobar H; Yoshimi A; Hoffmann R; van Buiren M; Wild D; Folkens JU; Pohl M; Kontny U
Klin Padiatr; 2012 Apr; 224(3):191-2. PubMed ID: 22513794
[No Abstract] [Full Text] [Related]
2. [Malignant lymphoma: magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions].
Stroszczynski C; Hosten N; Oellinger J; Spahn G; Amthauer H; Bittner RC; Hierholzer J; Ludwig WD; Felix R
Rofo; 1999 Sep; 171(3):192-9. PubMed ID: 10520328
[TBL] [Abstract][Full Text] [Related]
3. Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
Advani R; Maeda L; Lavori P; Quon A; Hoppe R; Breslin S; Rosenberg SA; Horning SJ
J Clin Oncol; 2007 Sep; 25(25):3902-7. PubMed ID: 17664458
[TBL] [Abstract][Full Text] [Related]
4. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
5. Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.
Metwally H; Courbon F; David I; Filleron T; Blouet A; Rives M; Izar F; Zerdoud S; Plat G; Vial J; Robert A; Laprie A
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):793-9. PubMed ID: 20615626
[TBL] [Abstract][Full Text] [Related]
6. [Hodgkin's disease in pregnancy--case report and literature review].
Schäffer M; Hegenbart U; Klostermann K; Stepan H
Z Geburtshilfe Neonatol; 2003; 207(2):71-3. PubMed ID: 12740750
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
[TBL] [Abstract][Full Text] [Related]
8. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous granulomas as the first manifestation of Hodgkin's disease.
Macaya A; Servitje O; Moreno A; Peyrí J
Eur J Dermatol; 2003; 13(3):299-301. PubMed ID: 12804995
[TBL] [Abstract][Full Text] [Related]
10. Difficult Diagnosis between B Cell Lymphoma and Classical Hodgkin's Lymphoma.
Rentas Torres Y; Rodríguez-López JL; Valentin M; Silva H
Bol Asoc Med P R; 2015; 107(3):98-101. PubMed ID: 26742206
[TBL] [Abstract][Full Text] [Related]
11. Combined modality (ABVD plus radiotherapy) versus radiotherapy in the management of early stage (IIA) Hodgkin's disease with mediastinal involvement.
Anselmo AP; Bove M; Cartoni C; Damico C; Maurizi Enrici R; Falchetto Osti M; Biagini C
Haematologica; 1992; 77(2):177-9. PubMed ID: 1383107
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Zhen ZJ; Sun XF; Xia Y; Wang ZH; Ling JY
Ai Zheng; 2006 Apr; 25(4):471-5. PubMed ID: 16613683
[TBL] [Abstract][Full Text] [Related]
13. [Lipoid nephrosis in a child with advanced Hodgkin's lymphoma].
Gordillo Paniagua G; Velázquez Jones L; Scovino Gudiño R; Arroyo Sierra J; Silva Sosa M; Mota Hernández F
Bol Med Hosp Infant Mex; 1977; 34(4):815-21. PubMed ID: 911442
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin's disease--clinical trials and travails.
DeVita VT
N Engl J Med; 2003 Jun; 348(24):2375-6. PubMed ID: 12802021
[No Abstract] [Full Text] [Related]
15. [Nephrotic syndrome in Hodgkin's disease].
Miltényi Z; Keresztes K; Ujhelyi L; Kovács J; Illés A
Orv Hetil; 2005 Jun; 146(25):1357-60. PubMed ID: 16106759
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin lymphoma presenting with hair graying.
Trakymiene SS; Abla O
J Pediatr Hematol Oncol; 2010 Jul; 32(5):417-8. PubMed ID: 20502355
[No Abstract] [Full Text] [Related]
17. Chemotherapy for Hodgkin's disease.
Ekert H
N Engl J Med; 2003 Sep; 349(12):1186-7; author reply 1186-7. PubMed ID: 13679536
[No Abstract] [Full Text] [Related]
18. Lymphoma in the Waldeyer ring: a great masquerader.
Osborne RF; Hamilton JS; Avitia S
Ear Nose Throat J; 2009 Jun; 88(6):954-6. PubMed ID: 19517398
[No Abstract] [Full Text] [Related]
19. Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.
Hohaus S; Di Febo A; Storti S; Teofili L; Voso MT; Leone G
Haematologica; 2004 Jun; 89(6):751-2. PubMed ID: 15194545
[TBL] [Abstract][Full Text] [Related]
20. ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial.
Hancock BW; Gregory WM; Cullen MH; Hudson GV; Burton A; Selby P; Maclennan KA; Jack A; Bessell EM; Smith P; Linch DC; ;
Br J Cancer; 2001 May; 84(10):1293-300. PubMed ID: 11355937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
